…[I]n recent years, finding the secret to longer life has transitioned from mythical fiction to actual science with the help of over $5 billion in investments from the likes of Peter Thiel, Jeff Bezos and Sam Altman.
This ultra-wealthy cohort is laser-focused on preventing aging at the molecular level, while others are funneling cash into battling more tangible age-related diseases like Parkinson’s.
And while you may have heard of Bezos-backed Altos Labs or Thiel favorite Methuselah, the Singapore-based longevity fund Immortal Dragons is making its own progress on the not dying front ….
Boyang Wang, the CEO of Immortal Dragons, is only 34, longevity has interested him for years.
…
Related on the SLP
In December 2023, with several successful startups under his belt, he launched Immortal Dragons, funneling about $4 million from family and friends and $36 million of his own money. The goal is to invest in “moonshot initiatives,” … with big risks and big rewards.
For example, one firm doing quite well in the Immortal Dragons portfolio is Frontier Bio, which is developing 3D biofabrication techniques that would allow new organs to be printed instead of relying on donors.


















